Literature DB >> 10644302

Barrett's oesophagus and proton pump inhibitors: a pathological perspective.

N A Shepherd1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10644302      PMCID： PMC1727813          DOI： 10.1136/gut.46.2.147

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  24 in total

1.  Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.

Authors:  R E Sampliner; K Steinbronn; H S Garewal; R H Riddell
Journal:  Am J Gastroenterol       Date:  1988-05       Impact factor: 10.864

2.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

Authors:  H Barr; N A Shepherd; A Dix; D J Roberts; W C Tan; N Krasner
Journal:  Lancet       Date:  1996-08-31       Impact factor: 79.321

3.  Continuing climb in rates of esophageal adenocarcinoma: an update.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

4.  Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Authors:  F T Peters; S Ganesh; E J Kuipers; W J Sluiter; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

5.  Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy.

Authors:  S Gore; C J Healey; R Sutton; I A Eyre-Brook; M W Gear; N A Shepherd; S P Wilkinson
Journal:  Aliment Pharmacol Ther       Date:  1993-12       Impact factor: 8.171

6.  Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

7.  Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.

Authors:  J Jankowski; D Hopwood; R Pringle; K G Wormsley
Journal:  Am J Gastroenterol       Date:  1993-03       Impact factor: 10.864

8.  Partial regression of Barrett's esophagus--an inadequate endpoint.

Authors:  R E Sampliner; R Fass
Journal:  Am J Gastroenterol       Date:  1993-12       Impact factor: 10.864

9.  Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.

Authors:  M F Vaezi; J E Richter
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

Authors:  M M Berenson; T D Johnson; N R Markowitz; K N Buchi; W S Samowitz
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682
View more
  3 in total

1.  Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

Authors:  Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

2.  Proliferative activity in Barrett's esophagus before and after antireflux surgery.

Authors:  L Q Chen; C Y Hu; L Gaboury; M Pera; P Ferraro; A C Duranceau
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

3.  Medication usage and the risk of neoplasia in patients with Barrett's esophagus.

Authors:  Dang M Nguyen; Hashem B El-Serag; Louise Henderson; Daniel Stein; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.